Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-13 Sale | 2024-03-14 4:17 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 11,220 | $57.56 | $645,838 | 56,287 (Direct) | View |
| 2024-01-29 Sale | 2024-01-31 4:31 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 835 | $64.14 | $53,555 | 67,507 (Direct) | View |
| 2024-01-22 Sale | 2024-01-23 6:11 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 2,593 | $65 | $168,535 | 68,342 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 4:40 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 1,857 | $66.81 | $124,064 | 99,302 (Direct) | View |
| 2023-09-18 Sale | 2023-09-19 5:03 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 20,350 | $44.27 | $900,813 | 168,565 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-16 Option Award | 2024-01-17 4:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 19,508 | $0 | 99,302 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:40 pm | N/A 2034-01-15 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 28,367 | $66.3 | 99,302 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-19 5:03 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 9,719 | $29.76 | 168,565 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-19 5:03 pm | N/A 2030-08-16 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 9,719 | $0 | 168,565 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-22 06:45 am | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 23,909 | $0 | 77,526 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 06:45 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 825 | $58.5 | 77,526 (Direct) | View |
| 2023-01-27 Tax Withholding | 2023-01-30 5:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 551 | $52.77 | 54,442 (Direct) | View |
| 2023-01-20 Tax Withholding | 2023-01-24 5:21 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 2,034 | $52.05 | 54,993 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:41 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 22,580 | $0 | 94,374 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:41 pm | N/A 2033-01-11 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 35,472 | $52.66 | 94,374 (Direct) | View |
| 2022-04-25 Other | 2023-01-17 7:41 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 13,125 | $0 | 94,374 (Direct) | View |
| 2022-01-28 Tax Withholding | 2022-02-01 6:06 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 650 | $38.59 | 35,555 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:51 pm | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 63,002 | $0 | 73,156 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:38 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 65,625 | $0 | 65,625 (Direct) | View |
Ownership | 2020-10-06 4:39 pm | N/A 2030-08-16 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 0 | $0 | 125,000 (Direct) | View |